{"nctId":"NCT00932321","briefTitle":"Study of Safety and Efficacy of an Oral Contraceptive","startDateStruct":{"date":"2004-01"},"conditions":["Prevention of Pregnancy"],"count":938,"armGroups":[{"label":"24 Day NA/EE","type":"EXPERIMENTAL","interventionNames":["Drug: Norethindrone Acetate/Ethinyl Estradiol 24 Days"]},{"label":"21 Day NA/EE","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Norethindrone Acetate /Ethinyl Estradiol 21 Days"]}],"interventions":[{"name":"Norethindrone Acetate/Ethinyl Estradiol 24 Days","otherNames":[]},{"name":"Norethindrone Acetate /Ethinyl Estradiol 21 Days","otherNames":["21 Day NA/EE"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Healthy Women\n* Age 18-45\n* At risk for pregnancy\n* History of regular cycles\n\nExclusion Criteria:\n\n* Contraindications for use of hormonal contraception\n* Conditions which affect the absorption or metabolism of steroid hormones\n* BMI \\> 35","healthyVolunteers":true,"sex":"FEMALE","minimumAge":"18 Years","maximumAge":"45 Years","stdAges":["ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Pregnancy Rate (Expressed as Pearl Index) for Women 18 to 45 Years Old, MITT Population","description":"Pearl Index = 1300 \\* number of pregnancies/number of women-cycles of treatment","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.823","spread":null},{"groupId":"OG001","value":"2.978","spread":null}]}]}]},{"type":"SECONDARY","title":"Mean Number of Intracyclic Bleeding (IB)/Spotting Days in Cycles 2-6, MITT Population","description":"Self-reported via patient completed diary (none - no vaginal bleeding, light - less than normal menstruation, normal - like normal menstruation, heavy - more than normal menstruation) along with daily use of sanitary protection (other than panty liners). Light bleeding requiring no more than single pad or tampon will be spotting.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6.31","spread":"9.16"},{"groupId":"OG001","value":"7.31","spread":"10.51"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":3,"n":743},"commonTop":["Headache","Vaginal Candidiasis","Upper Respiratory Tract Infection","Nausea","Dysmenorrhea"]}}}